{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:02:21Z","timestamp":1788346941870,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.pathol.2019.11.007","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T23:53:18Z","timestamp":1582588398000},"page":"318-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["PD-L1 expression in papillary thyroid cancer with and without lymphocytic thyroiditis: a cross sectional study"],"prefix":"10.1016","volume":"52","author":[{"given":"Mitali","family":"Fadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-9733","authenticated-orcid":false,"given":"Prishila","family":"Fookeerah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-8381","authenticated-orcid":false,"given":"Sayed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Shadbolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Greenaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7369-5937","authenticated-orcid":false,"given":"Sumathy","family":"Perampalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.11.007_bib1","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.immuni.2016.04.023","article-title":"Targeting T cell co-receptors for cancer therapy","volume":"44","author":"Callahan","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.pathol.2019.11.007_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/ERC-16-0421","article-title":"Comprehensive screening for PD-L1 expression in thyroid cancer","volume":"24","author":"Ahn","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.pathol.2019.11.007_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/thy.2016.0228","article-title":"Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathologic factors and recurrence","volume":"27","author":"Shi","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.pathol.2019.11.007_bib4","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1210\/jc.2015-4227","article-title":"Tumor-infiltrating T cells and the PD-1 checkpoint pathway in advanced differentiated and anaplastic thyroid cancer","volume":"101","author":"Bastman","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2019.11.007_bib5","doi-asserted-by":"crossref","first-page":"32318","DOI":"10.18632\/oncotarget.8698","article-title":"Programmed death-liagand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants","volume":"7","author":"Chowdhury","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2019.11.007_bib6","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1089\/thy.2014.0134","article-title":"BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive cell infiltration","volume":"24","author":"Angell","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.pathol.2019.11.007_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/ERC-12-0313","article-title":"Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation","volume":"20","author":"Cunha","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.pathol.2019.11.007_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PAI.0000000000000531","article-title":"Comparison of different antibody clones for immunohistochemistry detection of PD-L1 on non-small cell carcinoma","volume":"26","author":"Parra","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.pathol.2019.11.007_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtho.2016.11.2228","article-title":"PD-L1 immunohistochemistry assays for lung cancer: results from Phase 1 of the blueprint PD-L1 IHC assay comparison project","volume":"12","author":"Hirsch","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2019.11.007_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.autrev.2017.05.025","article-title":"Targeting programmed cell death 1 pathway in rheumatoid arthritis","volume":"16","author":"Sandigursky","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pathol.2019.11.007_bib11","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2009-2564","article-title":"Tumour associated and increased FoxP3\u00a0+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer","volume":"95","author":"French","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2019.11.007_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/thy.2013.0062","article-title":"Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis","volume":"24","author":"McLeod","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.pathol.2019.11.007_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.1998.8.197","article-title":"Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma","volume":"3","author":"Kashima","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.pathol.2019.11.007_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s002680020165","article-title":"Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited","volume":"25","author":"Kebebew","year":"2001","journal-title":"World\u00a0J Surg"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302520304578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302520304578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T10:26:25Z","timestamp":1710498385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302520304578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0031302520304578"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.11.007","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 expression in papillary thyroid cancer with and without lymphocytic thyroiditis: a cross sectional study","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}